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Interactions With Granulocyte-Macrophage Colony-Stimulating Factor 
By Leif Stenke, Mahmoud Mansour, Peter Reizenstein, and Jan Ake Lindgren 
The regulatory role of leukotrienes (LT) on human myelo- 
poiesis was investigated. Mononuclear bone marrow cells 
from 31 healthy donors were cultivated  in the presence of 
suboptimal  concentrations of  recombinant granulocyte- 
macrophage  colony-stimulating factor  (GM-CSF) for  10 
days in semisolid agar. The addition of LTC,  or LTB4  to the 
cultures dose-dependently stimulated myeloid stem cell 
proliferation.  Maximal effects were observed at 1  O-* mol/ 
L, at which LTC,  induced a 91  % & 23%  (mean & SEM; P 
= .004) and LTB,  a 73% f  22% (P = .008)  increase in 
colony formation. In contrast, addition of the LTB,  isomer 
5(S), 12(S)-diHETE  did not affect  the growth. LT D4  exerted 
a weak potentiating  effect on progenitor proliferation  (1  7% 
YELOID CELLS, including granulocytes and mono-  M  cytes, convert arachidonic acid to leukotrienes (LT) 
via the  5-lipoxygenase pathway.’ LTB4 potently promotes 
physiologic, inflammatory events, such as adhesion to the 
vessel wall, chemotaxis, and degranulation of granulocytes. 
The cysteinyl leukotrienes LTC4, LTD,,  and LTE4 induce 
plasma leakage and are important asthma mediators, inducing 
smooth  muscle contraction,  increased microvascular per- 
meability, and mucus secretion.’ In addition, a number of 
reports during recent years have indicated that the LTs also 
possess modulatory effects on cell proliferation. Both LTBI 
and LTC4 have been demonstrated to increase the in vitro 
growth of  arterial smooth  muscle cells,* airway epithelial 
cells,3 and mitogen-stimulated  lymphocyte^.^ In cultures of 
human bone marrow (BM) cells, the effect of LTs has ap- 
peared less consistent. Thus, in an early report, LTB4 was 
claimed to stimulate  the  formation  of  myeloid colonie~.~ 
Furthermore, a similar role was suggested for LTC4,  because 
this compound reversed the suppression of colony formation 
induced by lipoxygenase inhibitors6  However, these results 
were disputed by  others who proposed inhibitory effects of 
both LTB, and LTC4.’ In the present study, we have therefore 
reinvestigated the role of LTs in human myelopoiesis using 
normal  human  mononuclear  BM  cells stimulated  with a 
suboptimal concentration of recombinant granulocyte-mac- 
rophage colony-stimulating factor (GM-CSF). 
From the Department of Physiological Chemistry, Karolinska In- 
stitutet;  and  the  Hematology  Laboratory,  Karolinska  Hospital, 
Stockholm, Sweden. 
Submitted April 28, 1992; accepted September 14, 1992. 
Supported by grants  from the Swedish Cancer Society (Project No. 
26631, the Swedish Society of Medicine, Svenska Sallskapet  fdr Med- 
icinsk Forskning, the King Gustaf VJubilee Foundation, UlfLundahl3 
Foundation, Lars Hierta’s Memorial Foundation, and the Research 
Funds of Karolinska Institutet. 
Address reprint requests to LeifStenke, MD, PhD, Department of 
Physiological Chemistry, Karolinska Institutet, Box 60 400, S-10401 
Stockholm, Sweden. 
The publication costs of this article were defiayed in part by page 
charge payment.  This  article  must  therefore be  hereby  marked 
“advertisement” in accordance with 18 U.S.C. section I734 solely to 
indicate this fact. 
0 I993 by The American Society of Hematology. 
0006-49  71/93/81  02-0005$3.00/0 
&  7% growth stimulation at  mol/L;  P  =  .034), 
whereas LTE4  was without consistent effect. Furthermore, 
LTC4-induced stimulation of colony formation was insen- 
sitive to the LTD,  antagonist IC1 19861  5. The dual lipox- 
ygenase and prostaglandin endoperoxide synthase inhibitor 
CL42A  potently suppressed the proliferation of  myeloid 
colonies, a suppression that could be reversed by parallel 
addition of  LTB,  or  LTC,.  The results suggest that both 
LTB4 and  LTC4 possess  strong  and specific  synergistic 
stimulatory effects on GM-CSF-induced  human myeloid 
progenitor cell growth. 
0  1993 by  The American Society of Hematology. 
MATERIALS  AND  METHODS 
Reagents.  LTB4, LTC4, LTDI, and LTE4 were kind gifts from 
Dr T. Miyamoto (ONO Company, Osaka, Japan). Biosynthetic 5(S), 
I2(S)-dihydroxyeicosatetraenoic acid [5(S),  I2(S)-diHETE] was pre- 
pared as described.8  The identities of the compounds were routinely 
checked by  UV-spectroscopy and high performance liquid chroma- 
tography (HPLC). The sulfasalazine analogue CL42A [5’-(2,4-dich- 
1orobenzoyl)T-hydroxyphenyl-acetic  acid] and the LTD4 antagonist 
IC1  1986  15 were generously supplied by  Pharmacia AB (Uppsala, 
Sweden) and Imperial Chemical Industries PLC (Cheshire, UK), re- 
spectively. Ficoll-Hypaque was  purchased  from  Pharmacia  Fine 
Chemicals (Uppsala, Sweden) and Escherichia coli-derived recom- 
binant human GM-CSF from Amersham Intemational (Amersham, 
UK). GIBCO (Paisley, UK) supplied fetal calf serum (FCS), Iscove’s 
medium  (Dulbecco’s formulation),  and phosphate-buffered saline 
(PBS; Dulbecco’s formulation, 0.9 mmol calcium/L, pH 7.4). Bacto- 
Agar was from Difco Laboratories (Detroit, MI). 
Human BM cells from 3 I  healthy, medicine- 
free volunteers were collected into heparinized tubes (50 U/mL) by 
needle aspiration from the iliac crest. Informed consent was obtained 
from each individual and the project was approved by  the Ethical 
Committee of Karolinska Institutet. Mononuclear cells were isolated 
by separation on a Ficoll-Hypaque gradient. After centrifugation at 
400g for 30 minutes, cells in the interphase layer were collected and 
washed three times in PBS. Staining with Turk’s solution demon- 
strated a cell population with more than 97% mononuclear cells. The 
viability of these cells was more than 95% as judged by  the trypan 
blue exclusion test. 
Colony assay.  The mononuclear BM cells were resuspended in 
a mixture of Iscove’s medium with 10% FCS and 0.3% agar. One- 
milliliter portions of the cell suspensions, containing 0.2 X  IO6 cells, 
were placed in Petri dishes on top of a I-mL feeder layer. The feeder 
contained 0.5% agar in Iscove’s medium and recombinant  human 
GM-CSF. Dose-response  curves from preliminary experiments dem- 
onstrated an optimal progenitor cell growth in the presence of 25 U 
(equivalent to 0.5 ng) GM-CSF per dish. Suboptimal concentrations 
ofGM-CSF (12.5 U per dish) were used in the experiments to facilitate 
the estimation of modulatory effects exerted by  added substances. 
Various concentrations of LTs and other specified compounds were 
added from stock solutions in ethanol to the cell layers during plating. 
The final ethanol concentration in the dishes never exceeded 0.0570, 
a concentration that by itself did not affect colony growth. All cultures 
were incubated for 10 days at 37°C in a cell incubator with an au- 
tomatically regulated fully humidified atmosphere of 5% CO2 in air. 
Control dishes were made in sets of six and all other dishes in trip- 
licates. The dishes were code-numbered and scored blindly directly 
after the IO-day cultivation using an inverted microscope (Zeiss, Ob- 
Cell preparations. 
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Fig 1.  Effect  of LTC,  on human myeloid progenitor cell growth. 
The colany  formation in  GM-CSF-stimulated BM cultures cultivated 
in  the presence of LTC,  (1  O-',  to lo-"  mol/L) was compared with 
that of corresponding  control  cultures grown in  the absence of LTC,. 
The number of colonies was scored after 10  days. The bars represent 
the mean values + SEM from experiments with BM cells from 5 
to  26  healthy volunteers (LTC,:  lo-',  mol/L, n = 6;  mol/L, 
n = 9;  lO-'Omol/L,  n = 26;  10-8  mol/L, n = 9;  lO-'mol/L,  n 
= 5). Statistical analyses were performed against control dishes 
(paired t-test). **P  < .01; ***P  < .001. 
erkochen, Germany). Colonies were defined as  aggregates consisting 
of 40  cells or more. Experiments with a mean growth of less than 20 
colonies per dish in the controls were excluded. The growth in test 
dishes was  compared with that in parallel control dishes,  and the 
relative differences between mean values of sets of control and test 
dishes were analyzed using the two-tailed Student's  t-test for paired 
samples. 
RESULTS 
Efects  of  GM-CSF  or  LTs  on  BM  colony forma- 
tion.  Addition ofGM-CSF at suboptimal (12.5 U per dish) 
or optimal concentrations (25 U per dish) to agar mixtures 
of mononuclear BM  cells and serum induced a mean growth 
of 75 f  8 (mean k SEM; range, 23 to 194) or  I12 f  12 
(range, 28 to 223) colonies per dish, respectively (n = 31; P 
= .Oms), after IO days of cultivation. When LTB,  or LTC, 
(  IO-'2 to  mol/L) were added in the absence of GM-CSF, 
no colonies or cell clusters (8 to 40 cells) could be  recovered. 
In the experiments reported below, the suboptimal GM-CSF 
concentration (12.5 U per dish) was used in all culture dishes. 
Efects  of  LTs and 5(S),I2(S)-diHETE on  GM-CSF-in- 
duced BM colony formation.  LTC,  provoked  a dose-de- 
pendent increase in GM-CSF-induced  myeloid progenitor 
cell growth (Fig I).  Maximal effect was observed at IO-'  mol/ 
L LTC,,  which  stimulated the colony formation in 8 of 9 
tested BMs, with a mean increase of 91% ? 23% (P  = .004). 
The highest individual increase observed was 222%. Addition 
of  IO-" mol/L LTC, stimulated the growth in 22 of 26 tested 
BMs, with a mean increase of 38% f  9% (P  = .0003), whereas 
the corresponding result for  mol/L LTC,  was stimu- 
lation in 7 of 9 marrows, with a mean increase of 32% f  9% 
(P  = .006). In contrast, the highest and lowest concentrations 
of LTC,  (  and  IO-',  mol/L) failed to induce significant 
Table 1.  Effects  of LTD,  and LTE, 
on Human Myeloid Progenitor Cell Growth 
Colonies 
Concentration  (% of controls; 
Compound  (molar)  n  mean k SEM)  Significance 
LTD,  10-12  10  104  f  10  NS 
LTD,  10-10  12  1172 7  P = .034 
LTD,  10-0  12  139 f  25  NS 
NS 
LTE.  10-10  12  127 f  24  NS 
LTE,  10-8  12  132  f  22  NS 
127 f  31  LTE4  10-12  10 
The colony formation in GM-CSF-stimulated BM cultures cultivated in 
the presence of LTD,  or LTE,  (1  O-,  to 1  O-'  mol/L) was compared with 
that of corresponding control cultures grown in the absence of these 
compounds. The number of colonies was scored after 10 days.  Each 
number represents the mean values 2  SEM from experiments with BM 
cells from 10 to 12  individual donors. Statistical  analyses were performed 
against control dishes (paired 2-test). 
Abbreviation: NS,  not significant. 
stimulation (Fig 1). The stimulatory capacity of the related 
cysteinyl leukotrienes LTD,  and LTE,  (IO-'* to lo-* mol/ 
L) did not equal that of LTC,.  Thus, LTD,  produced a sig- 
nificant, but moderate stimulation at IO-''  mol/L (17% f 
7%; P = .034), whereas all other concentrations of  LTD4 
or LTE,  failed  to consistently influence colony formation 
(Table I). 
Addition of  LTB,  to GM-CSF-stimulated  BM  cultures 
also resulted in elevated colony formation (Fig 2). The stron- 
gest effect was observed with  lo-'  mol  LTB4/L, which  en- 
hanced the number of colonies in 9 of  IO BMs, with a max- 
imal increase of  164% and a mean increase of 73% f  22% 
(P  = .008).  The stimulatory capacity of LTB,  was significant 
also at lower concentrations, with 25% ? 1 1% (P  = .033) and 
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Fig 2.  Effect of (B)  LTB,  and (0)  S(S),lZ(S)-diHETE on human 
myeloid progenitor cell growth. The colony formation in GM-CSF- 
stimulated BM cultures cultivated in the presence of LTB,  (lo-" 
to lo-'  mol/L) or 5(S),12(S)-diETE  to lo-'  mol/L) was 
compared  with that of corresponding  control cultures grown in  the 
absence of these compounds. The number of colonies was scored 
after 10 days. The bars represent the mean values + SEM from 
experiments with BM cells from 5 to 23  healthy volunteers (LTB,: 
mol&  n = 10; 
lO-'mol/L,  n = 7;  5(S),12(S)-diETE: IO-'*mol/L,  n = 5; 
mol/L, n = 5;  lo-' mol/L, n = 7). Statistical analyses were per- 
formed against control dishes (paired  t-test). *P < .05;  **P  < .01. 
mol/L, n = 9;  mol/L, n = 23; 
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46% k  20% (P = .047) increases at  lo-''  mol/L and lo-'* 
mol/L, respectively. In contrast, addition of  mol LTB,/ 
L was without consistent effect. 
In parallel experiments, LTB4 was replaced by the double 
dioxygenation product 5(S),  12(S)-diHETE,  an LTB, isomer. 
As demonstrated in Fig 2, no effect on the colony formation 
could be observed after addition of 5(S),l2(S)-diHETE 
to IO-*  mol/L). 
There was no correlation between the stimulatory effects 
of the LTs and the number of colonies in control dishes. 
Effects of CL42A and ICI 198615 on BM colony forma- 
tion.  The sulfasalazine analogue CL42A was added to BM 
cultures either alone or in combination with LTB,  or LTC,. 
Addition of  10 pmol CL42A/L decreased the colony for- 
mation in 4 of 4 tested marrows (mean, 3  1  % f  10%  inhibition; 
P  = .05), whereas the presence of 50 pmol CL42A/L totally 
abolished the growth in all 3 tested BMs (P < .001). The 
moderate growth inhibition induced by  10 pmol CL42AIL 
was completely reversed by increasing concentrations of either 
LTB4 or LTC,  (Fig 3A). Furthermore,  either of these LTs 
could also partly restore the pronounced growth inhibition 
provoked by 50 pmol CL42A/L (Fig 3B). 
The effect of the LTD,  receptor antagonist IC1  198615 
( lo-'  mol/L) on progenitor cell proliferation was investigated 
in BM cultures from six donors (Fig 4). When added alone, 
IC1  198615 did not alter GM-CSF-induced  growth. More- 
over, the parallel addition of IC1 1986 15 to cultures stimulated 
with LTC, (lo-''  mol/L) did not significantly counteract the 
stimulatory effect exerted by this LT. 
DISCUSSION 
Hematologic cells are the principal producers of LTs. In 
humans, these compounds are readily produced, not only by 
LA lO-'*M  EA  10-loM  M 
A  T 
as 
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Fig 3.  Effect of CL42A on the growth of human myeloid progen- 
itor cells. GM-CSF-stimulated  BM  cells from two individual donors 
were cultivated with CL42A 10  pmol/L (A) or 50 pmol/L (B) in the 
presenceorabsenceof LTB40r  LTC4(10-'2, lo-",  and 10-8mol/ 
L.  respectively). The number of colonies was scored after 10  days. 
The bars represent mean relative colony formation + SEM of trip- 
licate determinations. 
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Fig 4.  Effect of IC1 19861  5 on LTC4-induced  stimulation of my- 
eloid progenitor cell growth. GM-CSF-stimulated  BM cells were 
cukivated in the presence of  LTC,  (lO-'O  mol/L), or  IC1 198615 
(lO-*mol/L)or LTC4(10-'0mol/L)combinedwithICI 198615 
mol/L). The number of colonies was scored after 10  days. The bars 
represent the mean values + SEM from experiments with BM  cells 
from six individual  donors. Statistical analyses were performed using 
paired t-test. 'P < .05. 
circulating leukocytes, but also by BM cells.'  It was therefore 
of interest to elucidate whether the LTs, which are potent 
regulators of leukocyte function, could also participate in the 
regulation of leukocyte formation. By investigating the effect 
of LTs on BM  specimens from a large number of healthy 
individuals, we  could clearly demonstrate that both  LTB, 
and LTC,  enhanced the proliferation of myeloid progenitor 
cells in vitro. This stimulatory action required the presence 
ofthe growth factor GM-CSF, a substance known to be crucial 
for the maintenance of normal human myelopoiesis."  The 
enhanced colony formation was observed already at pico- 
molar concentrations of LTC,  or LTB,,  with maximal effect 
of both compounds at lo-'  mol/L. Within this concentration 
range, these LTs induce a number of biologic events, such 
as LTB,-mediated neutrophil chemotaxis and LTC,-induced 
constriction of human bronchi.' 
A limited number of studies have previously addressed the 
question of whether LTs can influence human myelopoiesis. 
However, the published results have been contradictive. Thus, 
an initial study reported that addition  of LTB4 to growth 
factor-stimulated human BM cells induced a significant but 
moderate increase in the colony f~rmation.~  Another report 
disputed these results and stated that neither LTB,  nor LTC, 
or LTD4 could potentiate the growth when added alone to 
human myeloid progenitor cells in the presence of colony- 
stimulating factors6  However, these investigators also showed 
that nordihydroguaiaretic acid (NDGA), a dual lipoxygenase 
and prostaglandin endoperoxide synthase inhibitor, strongly 
reduced colony formation and that LTC, and LTD,, but not 
LTB,,  could reverse this inhibition.6 The opposite effects, ie, 
promotion of myeloid stem cell growth by  NDGA and in- 
hibition by  LTB4 or LTC,  (IO-'  to  mol/L), were later 
reported.'  The obviously discrepant conclusions of the various 
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studies may be explained by  several factors. First, various 
types and concentrations  of colony-stimulating factors, as 
well as different incubation techniques, were used. Second, 
different and sometimes unphysiologically high concentra- 
tions of LTs were used. Third, the use of the colony formation 
assay involves elements of subjectivity in the scoring proce- 
dure as well as a considerable interindividual sampling vari- 
ation. Therefore, it is advisable both to use a blinded scoring 
system and to examine a sufficient number of BMs. Notably, 
some of the proposed conclusions above were based on only 
two or three experiments. In the present study, using a large 
number of BMs, we have accumulated data that clearly sup- 
port a stimulatory role for LTC4 and LTB4 in human mye- 
lopoiesis. The investigation was facilitated by the use of a 
suboptimal concentration of recombinant human GM-CSF, 
which optimized the modulatory effects exerted by the tested 
compounds. 
Among the cysteinyl LTs, LTC4 was by  far the most ef- 
fective stimulator of myeloid progenitor cell growth, whereas 
LTD, possessed less activity and LTE4  was without significant 
effect. This is in good agreement with the mitogenic effects 
of these compounds in human airway epithelial cells.3 The 
results suggest that human myelopoiesis is modulated  via 
events depending on the binding of agonist to receptors spe- 
cific for LTC4 on myeloid progenitors or regulatory cells in 
the microenvironment.  This was also indicated by  the in- 
ability of the specific LTD,-antagonist  IC1 1986  15 to reverse 
the stimulatory effect of LTC, . While compelling evidence 
supports the existence of a specific LTD, receptor, the pres- 
ence of a distinct LTC, receptor has been questioned.''  How- 
ever, a receptor predominantly  activated by  LTC,  and in- 
sensitive  to LTD4-antagonists  has been described in the guinea 
pig ileum.'* In agreement, a receptor with the same specificity 
was recently also discovered in human vascular tissue (Dr 
S.-E. Dahltn, Karolinska Institutet, personal communication, 
April 1992). The true nature of the receptor involved in LTC,- 
induced stimulation of human myelopoiesis needs to be fur- 
ther elucidated. 
Proliferation of human myeloid progenitor cells was also 
stimulated by LTB4 with a potency similar to that of LTC,. 
In contrast, the LTB,-isomer  5(S),  12(S)-diHETE  was without 
effect. This is in agreement with a previous report in which 
5(S),  12(S)-diHETE was also suggested to antagonize the pos- 
itive effect of LTB4.5  The results indicate a structural speci- 
ficity of the LTB4-induced stimulation and suggest involve- 
ment of a specific LTB4 receptor in the signal transduction 
process. 
The dual 5-lipoxygenase and prostaglandin endoperoxide 
synthase inhibitor CL42AI3 suppressed myelopoiesis when 
added in the absence of exogenous LTs. This was most prob- 
ably due to attenuation of the endogenous LT formation, 
because earlier reports have demonstrated  that the myelo- 
poiesis is unaffected by  inhibition of the prostaglandin en- 
doperoxide synthase.14 The results indicate a modulatory role 
for endogenously formed  LTs in  myeloid progenitor  cell 
growth. Furthermore,  the inhibitory action of  CL42A was 
efficiently reversed by both LTB4  and LTC4.  The finding that 
the LTs  stimulated  myelopoiesis  also in  the  presence of 
CL42A excludes the possibility that the mitogenic effect on 
human myeloid BM  cells was mediated  via formation  of 
prostaglandin endoperoxide synthase products, as has earlier 
been reported for LTB4 in rat smooth muscle cells.'5 
In addition to the LTs, other bioactive lipoxygenase prod- 
ucts may also participate in the modulation of human mye- 
lopoiesis. Thus, we have recently demonstrated lipoxin (LX) 
formation from endogenous substrate in normal BM.I6 In 
addition, subnanomolar concentrations of both LXA4 and 
LXB,  stimulated  GM-CSF-induced  colony formation.  At 
higher concentrations, LXA,,  but not LXB4, could also re- 
verse LTC4-induced stimulation of colony growth. A similar 
dual role of LXA4 has previously been indicated  in other 
systems. Thus, this LX was demonstrated to stimulate neu- 
trophil migration,"  whereas preincubation of  human poly- 
morphonuclear granulocytes with LXA4 dose-dependently 
inhibited LTB4-induced chemotaxis.'* 
A pathophysiologic role for LTs, and possibly also for LXs, 
may be proposed in chronic myelogenous leukemia (CML). 
Consequently, the capacity of white blood cells from CML 
patients to synthesize LTC,  was significantly increased."  In 
contrast, CML platelets possessed a markedly decreased ca- 
pacity to participate in the transcellular synthesis of the po- 
tential  myelopoiesis  inhibitors  LXA4  and  5(S), 12(S)-di- 
HETE."  Moreover, the production of these compounds was 
totally abolished in platelets obtained from CML patients in 
blastic crisis. This pathologically altered formation of lipox- 
ygenase products  may thus contribute to the strongly en- 
hanced proliferation of myeloid cells in CML. 
The mechanisms by which LTs and LXs modulate mye- 
lopoiesis are essentially unknown. However, stimulation of 
progenitor cell growth induced by these compounds required 
the presence of GM-CSF. Furthermore, GM-CSF-induced 
stem cell growth was suppressed when the production of LTs 
and LXs was prevented by CL42A. These results suggest so- 
phisticated interactions  between GM-CSF and the lipoxy- 
genase products. Recent studies on hematopoiesis have dem- 
onstrated a complicated interplay between progenitor cells 
and other surrounding hematologic and nonhematologic cells. 
These interactions are mediated via the release of GM-CSF 
and other cytokines."  In the light of the present findings it 
is therefore of interest that priming with GM-CSF has been 
demonstrated to enhance LT synthesis in purified granulocyte 
suspensions and LX synthesis in platelet/granulocyte mix- 
ture~."-'~  In addition, cytopenic patients treated  with this 
growth factor showed an increased urinary excretion of cys- 
teinyl LTs.*~  Future studies using fractionated, well-defined 
cell populations and controlled growth conditions are needed 
to further clarify the precise role of lipoxygenase products in 
myelopoiesis. 
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